Haskell CM - Search Results

1

Systemic therapy for micrometastatic breast cancer.

Lindgren T, Haskell CM. Lindgren T, et al. Among authors: haskell cm. Cancer Invest. 1987;5(3):205-13. doi: 10.3109/07357908709011737. Cancer Invest. 1987. PMID: 2443225 Review. No abstract available.

2

Clinical thermochemotherapy. A controlled trial in advanced cancer patients.

Storm FK, Silberman AW, Ramming KR, Kaiser LR, Harrison WH, Elliott RS, Haskell CM, Sarna G, Morton DL. Storm FK, et al. Among authors: haskell cm. Cancer. 1984 Feb 15;53(4):863-8. doi: 10.1002/1097-0142(19840215)53:4<863::aid-cncr2820530408>3.0.co;2-f. Cancer. 1984. PMID: 6362831 Clinical Trial.

3

Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Does chemotherapy make a difference?

Ganz PA, Figlin RA, Haskell CM, La Soto N, Siau J. Ganz PA, et al. Among authors: haskell cm. Cancer. 1989 Apr 1;63(7):1271-8. doi: 10.1002/1097-0142(19890401)63:7<1271::aid-cncr2820630707>3.0.co;2-6. Cancer. 1989. PMID: 2465815 Clinical Trial.

4

Estimating the quality of life in a clinical trial of patients with metastatic lung cancer using the Karnofsky performance status and the Functional Living Index--Cancer.

Ganz PA, Haskell CM, Figlin RA, La Soto N, Siau J. Ganz PA, et al. Among authors: haskell cm. Cancer. 1988 Feb 15;61(4):849-56. doi: 10.1002/1097-0142(19880215)61:4<849::aid-cncr2820610435>3.0.co;2-b. Cancer. 1988. PMID: 3276389 Clinical Trial.

5

Phase I trial of extracellular adenosine 5'-triphosphate in patients with advanced cancer.

Haskell CM, Wong M, Williams A, Lee LY. Haskell CM, et al. Med Pediatr Oncol. 1996 Sep;27(3):165-73. doi: 10.1002/(SICI)1096-911X(199609)27:3<165::AID-MPO6>3.0.CO;2-C. Med Pediatr Oncol. 1996. PMID: 8699994 Clinical Trial.

6

p27(Kip1) and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapy.

Porter PL, Barlow WE, Yeh IT, Lin MG, Yuan XP, Donato E, Sledge GW, Shapiro CL, Ingle JN, Haskell CM, Albain KS, Roberts JM, Livingston RB, Hayes DF. Porter PL, et al. Among authors: haskell cm. J Natl Cancer Inst. 2006 Dec 6;98(23):1723-31. doi: 10.1093/jnci/djj467. J Natl Cancer Inst. 2006. PMID: 17148774 Free PMC article. Clinical Trial.

7

Corynebacterium parvum and metastatic breast cancer.

Haskell CM, Sarna GP, Liu PY. Haskell CM, et al. Br J Cancer. 1982 May;45(5):794-5. doi: 10.1038/bjc.1982.124. Br J Cancer. 1982. PMID: 7044404 Free PMC article. Clinical Trial. No abstract available.

8

Phase II study of intravenous adenosine 5'-triphosphate in patients with previously untreated stage IIIB and stage IV non-small cell lung cancer.

Haskell CM, Mendoza E, Pisters KM, Fossella FV, Figlin RA. Haskell CM, et al. Invest New Drugs. 1998;16(1):81-5. doi: 10.1023/a:1006018610986. Invest New Drugs. 1998. PMID: 9740548 Clinical Trial.

9

Systemic therapy for metastatic breast cancer.

Haskell CM, Sparks FC, Graze PR, Korenman SG. Haskell CM, et al. Ann Intern Med. 1977 Jan;86(1):68-80. doi: 10.7326/0003-4819-86-1-68. Ann Intern Med. 1977. PMID: 835932

10

Management of metastatic breast cancer.

Haskell CM. Haskell CM. Med Clin North Am. 1977 Sep;61(5):967-78. doi: 10.1016/s0025-7125(16)31273-1. Med Clin North Am. 1977. PMID: 330978 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters